Shardul Amarchand Mangaldas advises ChrysCapital on minority stake acquisition in Linux Laboratories
ChrysCapital Group has acquied a minority stake in Linux Laboratories Private Limited, a Chennai-based pharmaceutical company. The transaction comprises a secondary acquisition of shares from the Promoters and Tata Capital Healthcare Fund II and, a primary subscription to shares proposed to be issued by the Target Company. Shardul Amarchand Mangaldas & Co advised ChrysCapital Group on all legal aspects of the investment. The transaction was led by Karun Prakash (Partner) and Sangamitra Sankaraiah (Partner), with support from Simran Khullar (Senior Associate), Amrusha Monga (Senior Associate) and Aradhana Parmeshwar (Associate).
CounselShardul Amarchand Mangaldas
SectorPharma & Healthcare
Sources
Open in the live tracker →Related deals
- Shardul and Cyril Amarchand Mangaldas act on Elevate Campuses ₹2,100 crore IPO5 Oct 2026 · ₹2,100 cr
- Healthcare Global Enterprises Limited: General Updates5 Oct 2026 · ₹31,288
- Dr. Agarwal's Health Care Limited: Amalgamation/Merger5 Oct 2026
- Aurobindo Pharma Limited: General Updates2 Oct 2026
- Aurobindo Pharma Limited: Acquisition2 Oct 2026
- Aurobindo Pharma Limited: Acquisition1 Oct 2026